Man versus machine in in vitro fertilization-can artificial intelligence replace physicians?
Elnur Babayev
https://pubmed.ncbi.nlm.nih.gov/32819677Actively Recruiting
Led by Fundacion Dexeus · Updated on 2026-04-22
644
Participants Needed
5
Research Sites
21 weeks
Total Duration
Researchers are investigating whether using artificial intelligence (AI) to guide monitoring and timing of ovulation trigger in women undergoing ovarian stimulation for in vitro fertilization (IVF) can achieve clinical outcomes similar to traditional physician-led decisions. This trial aims to compare AI-assisted decision-making with routine clinical management to optimize the number of eggs retrieved, improve workflow efficiency, and reduce clinical workload, especially weekend procedures. Participants will be randomly assigned to one of two groups: one where trigger decisions are made by the physician assisted by the AI software called STIMAI®, and the other where trigger timing is determined by the physician alone based on clinical judgement. The AI software analyzes patient data to predict the optimal trigger day, offering options for triggering today or tomorrow, while the physician makes the final decision. The study focuses on individualized treatment to improve outcomes and scheduling. During the study, participants will undergo controlled ovarian stimulation with regular monitoring including ultrasounds. Researchers will measure the number of mature eggs retrieved about 34-36 hours after ovulation trigger, as well as other outcomes like follicle counts, length of stimulation, and number of clinic visits. The trial also tracks spontaneous ovulation and the distribution of retrieval procedures throughout the week. Participation will last through the stimulation cycle until egg retrieval, with assessments of both clinical results and process efficiency.
CONDITIONS
AI-TOP Study Artificial Intelligence for Trigger Optimization.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 8 to 15 days
Participants undergo controlled ovarian stimulation with trigger timing decided either by the physician assisted by AI guidance or by the physician alone following routine clinical management.
Up to 8 to 12 visits for monitoring and stimulation
Duration - Approximately 1 day
Participants attend follow-up visits for oocyte retrieval approximately 34 to 36 hours after ovulation trigger and assessment of clinical outcomes.
1 visit (in-person) for oocyte retrieval and assessment
Total: 5 locations
1
Dexeus Mujer Sabadell
Sabadell, Barcelona, Spain
Not Yet Recruiting
2
Dexeus Mujer Sant Cugat
Sant Cugat del Vallès, Barcelona, Spain, 08195
Not Yet Recruiting
3
Dexeus Mujer Reus
Reus, Tarragona, Spain, 43202
Not Yet Recruiting
4
Hospital Universitario Quiron Dexeus
Barcelona, Spain, 08028
Actively Recruiting
5
Dexeus Mujer Tarragona
Tarragona, Spain, 43206
Not Yet Recruiting
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Elnur Babayev
https://pubmed.ncbi.nlm.nih.gov/32819677Christophe Blockeel, Sara Engels, Michel De Vos...
https://pubmed.ncbi.nlm.nih.gov/22296973Chelsea Canon, Lily Leibner, Michael Fanton...
https://pubmed.ncbi.nlm.nih.gov/39164339Darren J X Chow, Philip Wijesinghe, Kishan Dholakia...
https://pubmed.ncbi.nlm.nih.gov/35118395Irene Dimitriadis, Nikica Zaninovic, Alejandro Chavez Badiola...
https://pubmed.ncbi.nlm.nih.gov/35027326Timothy Ferrand, Justine Boulant, Chloe He...
https://pubmed.ncbi.nlm.nih.gov/37581894Eduardo Hariton, Ethan A Chi, Gordon Chi...
https://pubmed.ncbi.nlm.nih.gov/34256948Gerard Letterie, Andrew MacDonald, Zhan Shi
https://pubmed.ncbi.nlm.nih.gov/34865998